Advantis Competitors

Stocks . USA . 
Stock . Advantis Corp
ADVT Stock  USD 0.0001  0.00  0.00%   
Advantis Corp competes with Silo Pharma, Protagenic Therapeutics, and Eledon Pharmaceuticals; as well as few others. The company conducts business under Pharmaceuticals sector and is part of Health Care industry. Analyzing Advantis Corp competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of Advantis Corp to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out Advantis Corp Correlation with its peers.
For more information on how to buy Advantis Stock please use our How to Invest in Advantis Corp guide.
You can use the Comparative Equity Analysis module to analyze the advantages of investing in your portfolio's related equities across multiple sectors and thematic ideas. Please use the input box below to enter symbols for particular investments you would like to analyze. With the equity comparison module, you can estimate the relative effect of Advantis Corp competition on your existing holdings.
  
Return On Tangible Assets is likely to drop to -0.21 in 2024. Return On Capital Employed is likely to drop to -0.28 in 2024. At this time, Advantis Corp's Total Assets are comparatively stable compared to the past year. Total Current Assets is likely to gain to about 324.8 K in 2024, whereas Return On Tangible Assets are likely to drop (0.21) in 2024.
Specify up to 10 symbols:
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Advantis Corp's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
0.000.00010.00
Details
Intrinsic
Valuation
LowRealHigh
0.000.0000840.00
Details
Naive
Forecast
LowNextHigh
0.00010.00010.0001
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
0.00010.00010.0001
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Advantis Corp. Your research has to be compared to or analyzed against Advantis Corp's peers to derive any actionable benefits. When done correctly, Advantis Corp's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Advantis Corp.

Advantis Corp Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Advantis Corp and its competitors represents the degree of relationship between the price movements of corresponding stocks. A correlation of about +1.0 implies that the price of Advantis and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Advantis Corp does not affect the price movement of the other competitor.
Click cells to compare fundamentals   Check Volatility   Backtest Portfolio
High positive correlations   
PTIX
+ 0.89
SILO
MRES
+ 0.44
SILO
HESG
+ 0.37
LVCLF
ELDN
+ 0.33
PTIX
MRES
+ 0.29
PTIX
ELDN
+ 0.19
SILO
  
High negative correlations   
HESG
- 0.68
SILO
HESG
- 0.65
PTIX
LVCLF
- 0.46
SILO
MRES
- 0.43
ELDN
LVCLF
- 0.43
PTIX
HESG
- 0.42
GSTC

Risk-Adjusted Indicators

There is a big difference between Advantis Stock performing well and Advantis Corp Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Advantis Corp's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
PKTX  7.44  0.35  0.03  0.40  8.95 
(10.69)
 17.14 
(19.67)
 56.34 
SILO  2.28  0.51  0.13  1.05  2.91 
(2.44)
 4.90 
(3.82)
 18.88 
GSTC  12.35  0.89  0.06  0.28  14.45 
(15.34)
 20.00 
(23.81)
 106.25 
NTRR  13.64  3.01  0.09 (0.98) 12.74 
(40.28)
 33.33 
(25.00)
 125.00 
PTIX  5.39  1.08  0.15  1.32  5.62 
(6.49)
 14.47 
(12.07)
 28.20 
ELDN  3.52  0.46  0.10  0.92  3.85 
(4.15)
 6.93 
(5.78)
 33.28 
LVCLF  2.87 (0.38) 0.00 (0.18) 0.00 
 0.00 
 0.00 
 0.00 
 104.22 
MRES  6.70  0.88  0.08 (109.42) 7.86 
(9.07)
 19.05 
(11.76)
 62.14 
HESG  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
 0.00 
 0.00 

Cross Equities Net Income Analysis

Compare Advantis Corp and related stocks such as Protokinetix, Silo Pharma, and AngioSoma Net Income Over Time
Select Fundamental
Price To Sales RatioPtb Ratio
Days Sales OutstandingBook Value Per Share
Free Cash Flow YieldInvested Capital
Operating Cash Flow Per ShareAverage Payables
Stock Based Compensation To RevenueCapex To Depreciation
Pb RatioEv To Sales
Free Cash Flow Per ShareRoic
Inventory TurnoverNet Income Per Share
Days Of Inventory On HandPayables Turnover
Sales General And Administrative To RevenueAverage Inventory
Research And Ddevelopement To RevenueCapex To Revenue
Cash Per SharePocfratio
Interest CoveragePayout Ratio
Capex To Operating Cash FlowPfcf Ratio
Days Payables OutstandingNet Current Asset Value
Income QualityRoe
Tangible Asset ValueEv To Operating Cash Flow
Pe RatioReturn On Tangible Assets
Ev To Free Cash FlowIntangibles To Total Assets
Net Debt To E B I T D ACurrent Ratio
Tangible Book Value Per ShareReceivables Turnover
Graham NumberShareholders Equity Per Share
Debt To EquityCapex Per Share
Graham Net NetAverage Receivables
Revenue Per ShareInterest Debt Per Share
Debt To AssetsEnterprise Value Over E B I T D A
Short Term Coverage RatiosPrice Earnings Ratio
Price Book Value RatioPrice Earnings To Growth Ratio
Days Of Payables OutstandingDividend Payout Ratio
Price To Operating Cash Flows RatioPrice To Free Cash Flows Ratio
Pretax Profit MarginEbt Per Ebit
Operating Profit MarginEffective Tax Rate
Company Equity MultiplierLong Term Debt To Capitalization
Total Debt To CapitalizationReturn On Capital Employed
Debt Equity RatioEbit Per Revenue
Quick RatioDividend Paid And Capex Coverage Ratio
Net Income Per E B TCash Ratio
Operating Cash Flow Sales RatioDays Of Inventory Outstanding
Days Of Sales OutstandingFree Cash Flow Operating Cash Flow Ratio
Cash Flow Coverage RatiosPrice To Book Ratio
Fixed Asset TurnoverCapital Expenditure Coverage Ratio
Price Cash Flow RatioEnterprise Value Multiple
Debt RatioCash Flow To Debt Ratio
Price Sales RatioReturn On Assets
Asset TurnoverNet Profit Margin
Gross Profit MarginPrice Fair Value
Return On EquityOperating Cycle
Cash Conversion Cycle
201020112012201320142015201620172018201920202021202220232024
PTIX(476 K)(476 K)(1 M)(1.1 M)(1.1 M)(476 K)(2.3 M)(2.3 M)(2.6 M)(1.8 M)(2.8 M)(5 M)(3.6 M)(5 M)(5.3 M)
ELDN(9.6 M)(9.6 M)(9.6 M)(15.7 M)(23.3 M)(45.1 M)(38 M)(13.1 M)(14.1 M)(17.9 M)(22.8 M)(34.5 M)(87.5 M)(40.3 M)(42.3 M)

Advantis Corp and related stocks such as Protokinetix, Silo Pharma, and AngioSoma Net Income description

Net income is one of the most important fundamental items in finance. It plays a large role in Advantis Corp financial statement analysis. It represents the amount of money remaining after all of Advantis Corp operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.

Advantis Corp Competitive Analysis

The better you understand Advantis Corp competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Advantis Corp's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Advantis Corp's competition over several years is one of the best ways to analyze its investment potential.
    
 Better Than Average     
    
 Worse Than Peers    View Performance Chart
ADVT PKTX SILO GSTC NTRR PTIX ELDN LVCLF MRES HESG
 0.00 
 0.0001 
Advantis
 2.15 
 0.02 
Protokinetix
 7.30 
 1.91 
Silo
 12.50 
 0.0009 
AngioSoma
 25.00 
 0.0003 
Neutra
 0.00 
 1.64 
Protagenic
 8.80 
 1.97 
Eledon
 0.00 
 0 
Living
 20.00 
 0.01 
Institute
 0.00 
 0.00001 
Health
Market Volatility
(90 Days Market Risk)
Very steady
Out of control
Very risky
Out of control
Out of control
Dangerous
Relatively risky
Out of control
Out of control
Out of control
Market Performance
(90 Days Performance)
Very Weak
OK
OK
Modest
OK
Good
Insignificant
Very Weak
OK
Very Weak
Odds of Financial Distress
(Probability Of Bankruptcy)
Very High
Below Average
Quite High
Above Average
Below Average
About Average
Low
Low
Low
Quite High
Current Valuation
(Equity Enterprise Value)
Over Valued
Over Valued
Under Valued
Over Valued
Over Valued
Under Valued
Under Valued
Over Valued
Over Valued
Fairly Valued
Buy or Sell Advice
(Average Analysts Consensus)
Not Available
Not Available
Not Available
Not Available
Not Available
Buy
Strong Buy
Not Available
Not Available
Not Available
Trade Advice
(90 Days Macroaxis Advice)
Strong Hold
Strong Hold
Strong Buy
Strong Hold
Cautious Hold
Hold
Strong Hold
Strong Hold
Cautious Hold
Hold
Current Ratio
N/A
0.54
33.28
N/A
0.04
19.47
22.22
17.84
N/A
0.01
Net Asset
268.98 K
446.23 K
7.75 M
9
130.93 K
4.32 M
125.89 M
4.27 M
5.28 M
1.03 M
EBITDA
N/A
(2.33 M)
(3.86 M)
(1.21 M)
(681.58 B)
(4.5 M)
(42.63 M)
(2.38 M)
N/A
(4.51 M)
Current Valuation
1.81 M
7.5 M
(2.06 M)
9.39 M
1.76 M
2.91 M
2.88 M
12.53 M
198.84 K
39.41 K
Price To Book
N/A
20.13
0.93
N/A
N/A
1.74
0.5
6.96
0.69
N/A
Operating Margin
N/A
N/A
-53.47
N/A
-3.99
N/A
N/A
-428.7
N/A
-73.91
Retained Earnings
(1.65 M)
(28.25 M)
(10.87 M)
N/A
(5.4 M)
(30.78 M)
(243.19 M)
(67 M)
(55.58 M)
(32.46 M)
Current Asset
24 K
180 K
N/A
N/A
1 K
3.75 M
N/A
6 M
2.56 M
67 K
Beta
29.19
0.13
1.35
1.17
2.86
0.38
0.93
0.27
1.71
-28.36
Number Of Employees
5
7
3
6
15
1
20
15
2
2
Shares Outstanding
N/A
316.85 M
2.84 M
770.36 M
2.3 B
4.44 M
24.81 M
1.29 B
66.28 M
N/A
Cash Flow From Operations
92.21 K
(889.89 K)
(3.22 M)
(327 K)
(405.62 K)
(3.7 M)
(39.53 M)
(2.04 M)
2.06 M
38.99 K
Annual Yield
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
0.0459
Total Debt
362.02 K
N/A
N/A
20 K
298.82 K
344.23 K
383 K
228.44 K
N/A
407 K
Return On Equity
N/A
-4.03
-0.44
N/A
N/A
-0.94
-0.48
-0.72
N/A
N/A
Z Score
N/A
N/A
N/A
N/A
N/A
N/A
N/A
5.4
-14.0
-61.4
Book Value Per Share
-0.003
0.001
2.13
-0.002
-0.001
0.83
3.45
0.003
N/A
-0.11
Return On Asset
N/A
-2.22
-0.25
-44.28
-1.81
-0.46
-0.3
-0.31
N/A
-0.73
Number Of Shares Shorted
N/A
N/A
61.39 K
N/A
N/A
11.33 K
106.87 K
N/A
N/A
N/A
Current Liabilities
554 K
40 K
N/A
N/A
459 K
736 K
N/A
1000 K
3.8 M
5.11 M
Total Asset
268.98 K
446.23 K
7.75 M
9
130.93 K
4.32 M
125.89 M
4.27 M
5.28 M
1.03 M
Debt To Equity
N/A
31.5
N/A
N/A
N/A
0.035
0.003
0.1
N/A
N/A
Short Ratio
N/A
N/A
0.46
N/A
N/A
0.6
0.99
N/A
N/A
N/A
Target Price
N/A
N/A
10.0
N/A
N/A
4.0
15.6
N/A
N/A
N/A
Shares Owned By Institutions
N/A
0.022
5.6
0.02
N/A
7.96
38.76
N/A
N/A
N/A
Market Capitalization
371
9.51 M
5.6 M
8.47 M
690.22 K
6.3 M
53.6 M
9.81 M
639.61 K
281
Price To Earning
-10.2
-9.86
118.39
N/A
-0.21
9.43
N/A
-31.67
N/A
N/A
Price To Earnings To Growth
N/A
N/A
N/A
-0.08
N/A
N/A
0.01
N/A
N/A
N/A
Price To Sales
1.47
N/A
77.69
78200.54
11.13
N/A
N/A
5586.88
N/A
0.0041
Net Income
(113.69 K)
(2.33 M)
(3.63 M)
(1.49 M)
(742.19 B)
(5 M)
(40.33 M)
(1.96 M)
564.67 K
(54.49 K)
Earnings Per Share
N/A
-0.009
-1.18
-0.018
N/A
-1.15
-1.64
-0.002
N/A
-0.13
Shares Owned By Insiders
N/A
30.73
6.35
10.02
0.86
21.83
5.42
33.99
N/A
N/A
Revenue
406.2 K
N/A
72.1 K
N/A
92.01 K
N/A
N/A
3.4 K
1.41 M
358.43 K
Working Capital
(530 K)
140 K
6.91 M
N/A
(458 K)
3.54 M
52.23 M
5 M
N/A
(5.04 M)
Cash And Equivalents
130.04 K
18.83 K
8.85 M
12
26.32 K
8.87 M
70.46 M
4.24 M
N/A
1.71 K
Cash Per Share
N/A
N/A
4.45
N/A
N/A
0.51
5.12
N/A
N/A
N/A
Gross Profit
N/A
N/A
66.26 K
(2.41 K)
31.16 K
N/A
N/A
3.4 K
N/A
22.91 K
Day Typical Price
1.0E-4
0.0177
1.95
9.0E-4
3.0E-4
1.55
2.04
0.0041
0.0132
0.0
Accumulation Distribution
N/A
15930.32
0.0591
0.11
N/A
1522.11
10991.45
N/A
N/A
N/A
Market Facilitation Index
N/A
N/A
0.12
1.0E-4
N/A
1.0E-4
0.0
N/A
N/A
N/A
Daily Balance Of Power
0.0
0.1
1.083333
1.0
(9,223,372,036,855)
N/A
(0.79)
0.0
9.2 T
9.2 T
Period Momentum Indicator
N/A
4.0E-4
0.13
1.0E-4
(0.0001)
N/A
(0.19)
N/A
0.0022
N/A
Rate Of Daily Change
1.0
1.02
1.07
1.13
0.75
1.0
0.91
1.0
1.2
9223372 T
Day Median Price
1.0E-4
0.017
1.97
9.0E-4
3.0E-4
1.51
2.08
0.0041
0.0132
0.0
Price Action Indicator
N/A
0.0022
0.005
1.0E-4
(0.00005)
0.13
(0.21)
N/A
0.0011
0.0
Relative Strength Index
N/A
48.87
69.48
34.5
47.93
66.07
43.8
34.47
60.09
N/A
Coefficient Of Variation
N/A
2361.19
555.4
1361.5
796.92
636.64
1009.79
(4,456)
1108.55
N/A
Mean Deviation
N/A
7.44
2.28
12.35
13.64
5.39
3.52
2.87
6.7
N/A
Jensen Alpha
N/A
0.352
0.5059
0.8867
3.01
1.08
0.4615
(0.38)
0.876
N/A
Total Risk Alpha
N/A
(1.03)
0.1247
(1.12)
(0.26)
0.1399
(0.21)
(1.79)
(0.47)
N/A
Sortino Ratio
N/A
0.0295
0.1277
0.0626
0.0907
0.1484
0.0998
N/A
0.0757
N/A
Downside Variance
N/A
150.21
13.28
360.3
875.0
51.66
17.98
N/A
108.97
N/A
Standard Deviation
N/A
10.78
3.11
17.47
22.14
7.4
5.24
11.2
9.81
N/A
Kurtosis
N/A
1.12
1.8
3.49
5.06
1.21
9.17
21.95
2.09
N/A
Potential Upside
N/A
17.14
4.9
20.0
33.33
14.47
6.93
N/A
19.05
N/A
Treynor Ratio
N/A
0.4034
1.05
0.2811
(0.98)
1.32
0.9219
(0.18)
(109.42)
N/A
Maximum Drawdown
N/A
56.34
18.88
106.25
125.0
28.2
33.28
104.22
62.14
N/A
Variance
N/A
116.11
9.7
305.14
490.03
54.73
27.42
125.41
96.32
N/A
Market Risk Adjusted Performance
N/A
0.4134
1.06
0.2911
(0.97)
1.33
0.9319
(0.17)
(109.41)
N/A
Risk Adjusted Performance
N/A
0.0358
0.1203
0.0554
0.088
0.1071
0.0706
(0)
0.0656
N/A
Skewness
N/A
0.3367
(0.56)
0.8592
1.39
0.4119
1.78
0.9581
0.1547
N/A
Semi Deviation
N/A
8.95
2.91
14.45
12.74
5.62
3.85
N/A
7.86
N/A
Information Ratio
N/A
0.0335
0.1494
0.068
0.1212
0.1442
0.0808
(0.03)
0.0805
N/A
Value At Risk
N/A
(19.67)
(3.82)
(23.81)
(25.00)
(12.07)
(5.78)
N/A
(11.76)
N/A
Expected Short fall
N/A
(10.69)
(2.44)
(15.34)
(40.28)
(6.49)
(4.15)
N/A
(9.07)
N/A
Downside Deviation
N/A
12.26
3.64
18.98
29.58
7.19
4.24
N/A
10.44
N/A
Semi Variance
N/A
80.13
8.47
208.86
162.26
31.55
14.81
N/A
61.79
N/A

Advantis Corp Competition Performance Charts

Five steps to successful analysis of Advantis Corp Competition

Advantis Corp's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Advantis Corp in relation to its competition. Advantis Corp's competition analysis typically involves several steps, including:
  • Identifying the key players in the market: This involves identifying the major competitors of Advantis Corp in the market, both direct and indirect, as well as new entrants and disruptive technologies.
  • Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
  • Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Advantis Corp's competitive landscape.
  • Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Advantis Corp, and developing a strategy to address them.
  • Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your Advantis Corp position

In addition to having Advantis Corp in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Social Domain Thematic Idea Now

Social Domain
Social Domain Theme
New or established large and mid-sized companies that are involved in the social media industry, including entities that provide web-based or mobile media applications and services across across large segment of population in multiple geographical areas. The Social Domain theme has 39 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Social Domain Theme or any other thematic opportunities.
View All  Next Launch
When determining whether Advantis Corp is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Advantis Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Advantis Corp Stock. Highlighted below are key reports to facilitate an investment decision about Advantis Corp Stock:
How To Invest In Advantis
Details
Is Advantis Stock a good investment?
Details
What is Advantis Corp's Net Worth?
Details
Largest Pharmaceuticals Companies
View
Largest Pharmaceuticals, Biotechnology & Life Sciences Companies
View
Check out Advantis Corp Correlation with its peers.
For more information on how to buy Advantis Stock please use our How to Invest in Advantis Corp guide.
You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.

Complementary Tools for Advantis Stock analysis

When running Advantis Corp's price analysis, check to measure Advantis Corp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Advantis Corp is operating at the current time. Most of Advantis Corp's value examination focuses on studying past and present price action to predict the probability of Advantis Corp's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Advantis Corp's price. Additionally, you may evaluate how the addition of Advantis Corp to your portfolios can decrease your overall portfolio volatility.
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Is Advantis Corp's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Advantis Corp. If investors know Advantis will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Advantis Corp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Advantis Corp is measured differently than its book value, which is the value of Advantis that is recorded on the company's balance sheet. Investors also form their own opinion of Advantis Corp's value that differs from its market value or its book value, called intrinsic value, which is Advantis Corp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Advantis Corp's market value can be influenced by many factors that don't directly affect Advantis Corp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Altman
Z Score
Details
Piotroski
F Score
Details
Beneish
M Score
Details
Financial
Analysis
Details
Buy or Sell
Advice
Details
Technical
Analysis
Details
Please note, there is a significant difference between Advantis Corp's value and its price as these two are different measures arrived at by different means. Investors typically determine if Advantis Corp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Advantis Corp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY